Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.


Goy A., Sinha R., Williams M. E. , Besisik S. , Drach J., Ramchandren R., ...More

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.31, no.29, pp.3688-95, 2013 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 29
  • Publication Date: 2013
  • Doi Number: 10.1200/jco.2013.49.2835
  • Journal Name: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.3688-95

Abstract

Purpose